We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Raw Fruit and Vegetable Diet Reduces Genetic Risk of Cardiovascular Disease

By LabMedica International staff writers
Posted on 25 Oct 2011
A recent paper revealed that a genetic trait that increases risk of developing cardiovascular disease could be mitigated by a diet rich in raw fruits and vegetables.

Investigators at McMaster University (Hamilton, Canada) together with colleagues at McGill University (Montreal, Canada) examined the effect of diet on the action of the chromosome 9p21 region of the human genome. More...
Mutations called single nucleotide polymorphisms (SNPs) in this region have been linked to risk of developing cardiovascular disease.

The investigators genotyped four 9p21 SNPs in 8,114 individuals of European, South Asian, Chinese, Latin American, or Arab ethnicity who were participants in the global INTERHEART study. Results of the gene mapping study were correlated with the composition of the diets adhered to by the various subjects.

Results published in the October 11, 2011, online edition of the journal PLoS Medicine revealed that individuals carrying the genotype that promoted high risk for cardiovascular disease who consumed a prudent diet, composed mainly of raw vegetables, fruits and berries, had a similar risk of heart attack to those with the low risk genotype.

“We observed that the effect of a high-risk genotype can be mitigated by consuming a diet high in fruits and vegetables,” said senior author Dr. Sonia Anand, professor of medicine and epidemiology at McMaster University. “Our results support the public health recommendation to consume more than five servings of fruits or vegetables as a way to promote good health.”

Related Links:
McMaster University
McGill University



New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HPV Molecular Test
BD Onclarity HPV Assay
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more

Pathology

view channel
Image: Spatial characterization of immune–tumor interactions and treatment response across SCLC and extended phenotype models (Cristian Barrera et al, npj Precision Oncology (2026). DOI: 10.1038/s41698-025-01225-9)

AI Pathology Tool Predicts Chemotherapy Response in Small Cell Lung Cancer

Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.